FMP
Once youngest female self-made billionaire, Elizabeth Holmes, is heading to trial.
Aug 28, 2021 2:14 AM - Davit Kirakosyan(Last modified: Dec 19, 2023 5:49 PM)
Image credit: FMP
Elizabeth Holmes, the founder and former CEO of Theranos, is heading to trial on September 8, with lawyers scheduled to select juries on Tuesday to decide the fate of the 37-year-old entrepreneur, who is charged with wire fraud and conspiracy.
Theranos reached a valuation of $10 billion in 2015, having around 800 employees and making Holmes the youngest self-made female billionaire.
Holmes, a Stanford dropout, who founded Theranos to revolutionize health care using a desktop analyzer that could perform a full range of accurate and reliable diagnostic tests using just a drop of blood, is now facing 20 years in prison.
According to prosecutors, Holmes misled investors and patients about the company’s technology, raising over $700 million worth of funds from VCs and private investors. Holmes pleaded not guilty and proclaims her actions were not to mislead them.
Other Blogs
Oct 31, 2023 8:03 AM - Parth Sanghvi
FCFF vs FCFE: What's the Difference?
Free cash flow to the firm (FCFF) and free cash flow to equity (FCFE) are two of the most important metrics used in financial modeling. Both metrics measure the amount of cash that is available to a company's shareholders and creditors, but there is a key difference between the two. FCFF measures...
Nov 25, 2023 6:39 AM - Parth Sanghvi
DCF Valuation vs. Comparable Companies Analysis: Choosing the Right Valuation Method
Choosing the Right Valuation Method: DCF vs. Comparable Companies Analysis Introduction: Valuation methods play a pivotal role in determining the fair value of a company, aiding investors in making informed investment decisions. Two commonly used methods, DCF Valuation and Comparable Companies A...
Dec 23, 2023 2:19 AM - Parth Sanghvi
Understanding the Limitations of DCF Analysis: A Guide to Overcoming Challenges
Introduction: Discounted Cash Flow (DCF) analysis stands as a cornerstone in valuing investments, yet its efficacy is contingent upon various assumptions and methodologies. While a powerful tool, DCF analysis comes with inherent limitations and challenges that investors must acknowledge to make i...
